PSIL vs. ARKG ETF Comparison
Comparison of AdvisorShares Psychedelics ETF (PSIL) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
PSIL
AdvisorShares Psychedelics ETF
PSIL Description
AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$12.13
Average Daily Volume
30,099
8
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$24.00
Average Daily Volume
1,832,233
34
Performance
| Period | PSIL | ARKG |
|---|---|---|
| 30 Days | 66.86% | -3.38% |
| 60 Days | 38.95% | -9.06% |
| 90 Days | 20.56% | -2.52% |
| 12 Months | -15.77% | -1.36% |
1 Overlapping Holdings
| Symbol | Grade | Weight in PSIL | Weight in ARKG | Overlap | |
|---|---|---|---|---|---|
| CMPS | F | 4.59% | 1.0% | 1.0% |
PSIL Underweight 33 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| TWST | F | -8.58% | |
| CRSP | C | -7.19% | |
| RXRX | F | -7.13% | |
| CDNA | D | -5.09% | |
| VCYT | A | -4.56% | |
| IONS | F | -4.4% | |
| ADPT | A | -4.37% | |
| NRIX | B | -4.29% | |
| NTLA | F | -3.81% | |
| NTRA | B | -3.75% | |
| TXG | F | -3.63% | |
| SDGR | F | -3.51% | |
| BEAM | F | -3.46% | |
| ARCT | F | -3.22% | |
| PSNL | C | -2.91% | |
| GH | D | -2.64% | |
| ABSI | D | -2.43% | |
| VEEV | B | -2.13% | |
| PACB | C | -2.11% | |
| AMGN | C | -1.94% | |
| VRTX | D | -1.56% | |
| ACCD | F | -1.42% | |
| BFLY | A | -1.32% | |
| EXAS | A | -1.26% | |
| INCY | A | -1.25% | |
| CERS | F | -1.12% | |
| REGN | F | -1.12% | |
| MRNA | F | -1.08% | |
| PRME | C | -0.92% | |
| MASS | F | -0.86% | |
| QSI | F | -0.73% | |
| RPTX | C | -0.72% | |
| ILMN | A | -0.26% |
PSIL: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords
Compare ETFs
